Precipio (PRPO) 8-K Regulation FD Disclosure

Revenue By Product Segment

WAVE

®

Mutation Detection Systems,

Consumables and SURVEYOR

®

Nuclease

Instrument Sales: $5.1M

Service Revenue: $5.4M

Consumable Sales: $8.7M

Pharmaceutical

and Academic

Services Lab

$1M

Molecular

Diagnostic

Laboratory

$1.7M

Cytogenetic

Instrumentation

$1.2M

2007 Forecast

$23.1M

EXHIBIT 99.1

0

100

200

300

400

500

600

1Q '06

2Q '06

3Q '06

4Q '06

1Q '07

2Q '07

3Q '07

4Q '07

Molecular Diagnostic Laboratory

Revenue ($K)

Forecast

0

100

200

300

400

500

1Q '06

2Q '06

3Q '06

4Q '06

1Q '07

2Q '07

3Q '07

4Q '07

Pharmacogenetics

Revenue ($K)

Forecast

Pathway to Success

•

Company Initiatives

–

Expand Molecular Diagnostics sales team

–

Leverage mitochondrial testing expertise to

expand menu tests ordered

–

Upgrade management team

–

Cash Retention

–

Reduced operating expenses $1.7 million

–

Trending to profitable performance

Historical Financial Summary

2008 Outlook

•

Revenue: Double-digit Growth

•

Continue Operating Efficiency Efforts

•

Profitable

•

Positive Cash Flow